AbbVie Inc.
ABBV Healthcare Drug Manufacturers General
AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow ABBV
AbbVie Inc. (ABBV) Book value per share
AbbVie Inc.'s book value per share at the end of fiscal 2025 was −1.8×, compared with 1.9× in fiscal 2024. At the end of the quarter to 30 June 2026 it was −3.3×. Over the past ten years it has ranged from −5.5× (fiscal 2019) to 9.8× (fiscal 2022); the current reading is higher than 27% of that period. AbbVie Inc. ranks 20th of 21 Drug Manufacturers General companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | −1.8× | — |
| FY2024 | 1.9× | (67.66%) |
| FY2023 | 5.9× | (39.75%) |
| FY2022 | 9.8× | 11.93% |
| FY2021 | 8.7× | 11.00% |
| FY2020 | 7.9× | — |
| FY2019 | −5.5× | — |
| FY2018 | −5.5× | — |
| FY2017 | 3.2× | 11.73% |
| FY2016 | 2.9× | 17.73% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | −3.3× | — |
| Mar 2026 | −3.7× | — |
| Dec 2025 | −1.8× | — |
| Sep 2025 | −1.5× | — |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| LLY Eli Lilly and Company compare | 38.0× |
| JNJ Johnson & Johnson compare | 35.3× |
| AZN AstraZeneca PLC compare | 32.5× |
| NVS Novartis AG compare | 22.0× |
| AMGN Amgen Inc. compare | 21.6× |
| MRK Merck & Co., Inc. compare | 17.0× |
| PFE Pfizer Inc. compare | 15.0× |
| GILD Gilead Sciences, Inc. compare | 9.4× |
| ABBV AbbVie Inc. | −3.3× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on ABBV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement